This compound is a modified purine nucleoside derivative with a 2-methoxyethoxy substituent on the ribose ring. It serves as a pharmaceutical intermediate used in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 440327-50-4
Guanosine, 2′-O-methyl-N-(2-methyl-1-oxopropyl)-
research compound
Guanosine, N-(2-methyl-1-oxopropyl)-
research compound
N2-ISOBUTYRYL-2'-FLUORO-2'-DEOXYGUANOSINE
pharmaceutical intermediate
N-methyliminodiacetic acid
pharmaceutical intermediate
N-(3-acetyl-4-(3-(ethylamino)-2-hydroxypropoxy)phenyl)butanamide
pharmaceutical intermediate
(2S,4S)-1-[(tert-Butoxy)carbonyl]-4-hydroxypiperidine-2-carboxylic acid
pharmaceutical intermediate
Cyclobutanemethanol
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
IZOOGJIUOCHAAY-UBEDBUPSSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)OCCOC